Evidence map›Paper›PMID 22015387›Full record

ArticleBiochimica et biophysica acta2012

Cytoskeleton disruption in J774 macrophages: consequences for lipid droplet formation and cholesterol flux.

Ginny L Weibel, Michelle R Joshi, W Gray Jerome, Sandra R Bates, Kevin J Yu, Michael C Phillips, George H Rothblat

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Progress in the Chemistry of Cytochalasans.Progress in the chemistry of organic natural products · 2021
    Article
  9. Article
  10. Immunomodulation of J774A.1 Murine Macrophages byFrontiers in microbiology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ginny L WeibelDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.
Michelle R Joshi
W Gray Jerome
Sandra R Bates
Kevin J Yu
Michael C Phillips
George H Rothblat
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USVanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
TISSUE CULTURE CORE LABORATORYP01HL022633 · NHLBI · MCP HAHNEMANN UNIVERSITY · PI LUND-KATZ, SISSEL · 1985 to 2013
$26.1M
UPTAKE AND REUTILIZATION OF SURFACTANT COMPONENTSP01HL019737 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FISHER, ARON B. · 1985 to 2013
$23.6M
Mechanism of Lysosome Functional Impairment in Cholesterol-engorged Foam CellsR01HL086746 · NHLBI · VANDERBILT UNIVERSITY · PI JEROME, WALTER G · 2008 to 2011
$1.3M
NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NHLBI NIH HHS HL-086746NHLBI NIH HHS HL-19737NHLBI NIH HHS HL-22633NHLBI NIH HHS P01 HL019737NHLBI NIH HHS P01 HL022633NHLBI NIH HHS R01 HL086746NIDDK NIH HHS DK20539NIDDK NIH HHS DK58404NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Macrophages store excess unesterified cholesterol (free, FC) in the form of cholesteryl ester (CE) in cytoplasmic lipid droplets. The hydrolysis of droplet-CE in peripheral foam cells is critical to HDL-promoted reverse cholesterol transport because it represents the first step in cellular cholesterol clearance, as only FC is effluxed from cells to HDL. Cytoplasmic lipid droplets move within the cell utilizing the cytoskeletal network, but, little is known about the influence of the cytoskeleton on lipid droplet formation. To understand this role we employed cytochalasin D (cyt.D) to promote actin depolymerization in J774 macrophages. Incubating J774 with acetylated LDL creates foam cells having a 4-fold increase in cellular cholesterol content (30-40% cholesterol present as cholesteryl ester (CE)) in cytoplasmic droplets. Lipid droplets formed in the presence of cyt.D are smaller in diameter. CE-deposition and -hydrolysis are decreased when cells are cholesterol-enriched in the presence of cyt.D or latrunculin A, another cytoskeleton disrupting agent. However, when lipid droplets formed in the presence of cyt.D are isolated and incubated with an exogenous CE hydrolase, the CE is more rapidly metabolized compared to droplets from control cells. This is apparently due to the smaller size and altered lipid composition of the droplets formed in the presence of cyt.D. Cytoskeletal proteins found on CE droplets influence droplet lipid composition and maturation in model foam cells. In J774 macrophages, cytoskeletal proteins are apparently involved in facilitating the interaction of lipid droplets and a cytosolic neutral CE hydrolase and may play a role in foam cell formation. This article is part of a Special Issue entitled Advances in High Density Lipoprotein Formation and Metabolism: A Tribute to John F. Oram (1945-2010).

Indexed as

Lipid MetabolismActin CytoskeletonAnimalsBridged Bicyclo Compounds, HeterocyclicCell LineCholesterol EstersCytochalasin DCytoskeletal ProteinsFoam CellsHydrolysisMiceOrganellesOrganelle SizeProteomeSterol EsteraseThiazolidinesBridged Bicyclo Compounds, HeterocyclicCholesterol EstersCytochalasin DCytoskeletal Proteinslatrunculin AProteomeSterol EsteraseThiazolidinesTriglycerides

Identifiers

PMID22015387
PMCPMC3274585
OpenAlexW2075231903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.